Interferon Clinical Trials

• Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Interferon Alfa in Treating Children With HIV-Related Cancer
  ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
  Leukemia; Lymphoma
  
• Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
  ClinicalTrials.gov Identifier: NCT00226408 - Recruiting
  Adjuvant; Stage III Malignant Melanoma; Interferon Alpha; Therapy
  
• Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
  ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
  recurrent adult brain tumor
  
• Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
  stage III melanoma
  
• Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
  Stage IV Melanoma
  
• Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
  primary systemic amyloidosis
  
• Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
  stage III melanoma
  
• Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00209118 - Active, not recruiting
  Hepatitis C; Depression; Interferon-Alpha Associated Side Effects
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
  ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
  Lymphoma
  
• Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
  ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
  Lymphoma; Multiple Myeloma
  
• Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
  Lymphoma; Leukemia
  
• Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Efficacy of Pegylated Interferon On Liver Fibrosis in Co-Infected Patient with HIV and C Hepatitis Who Failed to Active Treatment for HCV
  ClinicalTrials.gov Identifier: NCT00122616 - Active, not recruiting
  HIV Infections; Hepatitis C, Chronic
  
• Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Safety Study of Interferon Beta 1a to for Acute Stroke
  ClinicalTrials.gov Identifier: NCT00097318 - Active, not recruiting
  Cerebrovascular Accident
  
• Valopicitabine When Administered Alone and in Combination with Interferon to Treatment-Naive Patients with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00120835 - Active, not recruiting
  Chronic Hepatitis C
  
• A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
  Hepatitis C
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
  renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
  ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
  stage I melanoma; stage II melanoma; stage III melanoma
  
• Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Valopicitabine Alone and Together with Pegylated Interferon in Patients with Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00120861 - Active, not recruiting
  Chronic Hepatitis C
  
• Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
  ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
  HIV Infections
  
• Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
  Chronic Hepatitis C
  
• Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
  stage III melanoma
  
• Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
  Cancer
  
• PEDS-C: Pegylated Interferon +/- Ribavirin for Children with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00100659 - Active, not recruiting
  Chronic Hepatitis C
  
• Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Efficacy of Pegylated Interferon Alone in Egyptian Patients with Acute Hepatitis C (ANRS 1213)
  ClinicalTrials.gov Identifier: NCT00158522 - Recruiting
  Hepatitis C
  
• Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
  localized malignant mesothelioma
  
• Interferon-Gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-Responders
  ClinicalTrials.gov Identifier: NCT00538811 - Recruiting
  Hepatitis C; Genotype 3; Non-Responders; Relapsers
  
• Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00132210 - Recruiting
  Hepatitis C
  
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
  
• SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
  Renal Cell Carcinoma
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• Safety and Antifungal Activity of Recombinant Interferon-gamma 1b (rIFN-gamma 1b) Given with Standard Therapy in Patients with Cryptococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00012467 - Active, not recruiting
  Meningitis, Cryptococcal; HIV Infections
  
• Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
  Stage IV Renal Cell Cancer
  
• Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
  Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
  
• Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
  localized osteosarcoma; metastatic osteosarcoma
  
• Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
  recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
  
• Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma; Quality of Life
  
• Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
  iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00005665 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Genetic and Biochemical Markers of Interferon-Induced Depression.
  ClinicalTrials.gov Identifier: NCT00252538 - Recruiting
  Hepatitis; Depression
  
• Interferon-Alpha for Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00024518 - Active, not recruiting
  Insulin-Dependent Diabetes Mellitus
  
• Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
  stage III melanoma
  
• Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
  ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
  Hepatitis C
  
• Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
  ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
  stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma
  
• Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00082719 - Recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
  ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
  
• Cisplatin, Gemcitabine, Interferon alfa, and Hyperthermia in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004063 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma
  
• High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
  stage III melanoma; Recurrent Melanoma
  
• Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
  recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
  
• Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
  recurrent cervical cancer; stage IVB cervical cancer
  
• Therapy of Early Chronic Phase Chronic Myelogenous Leukemia with Gleevec, Alpha Interferon, and Ara-C
  ClinicalTrials.gov Identifier: NCT00048672 - Active, not recruiting
  Leukemia, Myeloid, Chronic-Phase
  
• PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• High-Dose Interferon alfa in Treating Patients With Stage II or Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00003641 - Recruiting
  stage II melanoma; stage III melanoma
  
• Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
  
• Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
  stage III melanoma; Recurrent Melanoma
  
• Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002771 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Interferon alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
  ClinicalTrials.gov Identifier: NCT00026416 - Active, not recruiting
  stage III adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIC adult soft tissue sarcoma; ...
  
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
  ClinicalTrials.gov Identifier: NCT00151801 - Recruiting
  Multiple Sclerosis
  
• Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
  ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
  Hepatitis C, Chronic; Fibrosis
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00004141 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
  ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) with Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
  ClinicalTrials.gov Identifier: NCT00038649 - Active, not recruiting
  Myelogenous Leukemia, Chronic, Chronic Phase
  
• Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00024271 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00065468 - Active, not recruiting
  Carcinoma, Renal Cell; Kidney Neoplasms
  
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
  ClinicalTrials.gov Identifier: NCT00162734 - Active, not recruiting
  Chronic Hepatitis C
  
• Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes
  ClinicalTrials.gov Identifier: NCT00324389 - Active, not recruiting
  Hepatitis C
  
• Immunotherapy Using Cyclosporine, Interferon gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070187 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
  chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Interferon alfa in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
  ClinicalTrials.gov Identifier: NCT00311558 - Active, not recruiting
  Cancer